While we're excited to reveal Riftbound Vendetta's Helm of Suppression, we're sorry in advance for all of the chaos it's ...
Initiated Himalayas-1 global Phase 3 trial in patients with mCRPC previously treated with abiraterone. Entered into a clinical trial collaboration and supply agreement with Bayer ...
Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat ...
Palisade Bio offers a speculative early-stage opportunity, advancing PALI-2108, a gut-restricted PDE4 inhibitor for UC and ...
Proprietary small-molecule formulation extends beyond conventional ROCK inhibitors to accelerate recovery and improve reproducibility in stem cell and organoid research. MONMOUTH JUNCTION, N.J., July ...
UAB researchers report Phase 1 trial results showing a novel immunotherapy safely doubled the time glioblastoma patients ...
SER-155 recipients achieved immunosuppressive-free clinical response of diarrhea (a primary symptom of irEC) at Day 15 in the ...
Subcutaneous amivantamab induced rapid and durable responses among patients with HPV-unrelated recurrent or metastatic head ...
Durable ZUMA-2 follow-up converted brexu-cel to traditional approval in r/r MCL, while sonrotoclax gained accelerated approval post-BTK inhibitor based on 52% ORR. Breast-cancer decisions expanded ...
Abbreviations: BICR, blinded independent central review; CBR, clinical benefit rate; CR, complete response; DoR, duration of response; NR, not reached; ORR, objective ...
Nathan Round, part of GameRant's talented Game Guides Team, is the leading voice for Call of Duty guides. From meta loadouts to the best weapons for each season, he takes pride in crafting top-notch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results